The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Tenet Healthcare Corp’s stock clocked out at $199.61, down -0.79% from its previous closing price of $201.2. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 1.11 million shares were traded. THC stock price reached its highest trading level at $200.07 during the session, while it also had its lowest trading level at $194.51.
Ratios:
To gain a deeper understanding of THC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.29 whereas as Long-Term Debt/Eq ratio is at 3.26.
Wells Fargo Upgraded its Equal Weight to Overweight on May 29, 2025, while the target price for the stock was maintained at $195.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 15 ’25 when West Nadja sold 2,178 shares for $197.47 per share. The transaction valued at 430,090 led to the insider holds 28,480 shares of the business.
West Nadja bought 2,178 shares of THC for $430,097 on Dec 15 ’25. On Nov 06 ’25, another insider, Ramsey R. Scott, who serves as the Principal Accounting Officer of the company, sold 13,322 shares for $205.11 each. As a result, the insider received 2,732,439 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 17635743744 and an Enterprise Value of 32440725504. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.68, and their Forward P/E ratio for the next fiscal year is 12.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 4.37. Its current Enterprise Value per Revenue stands at 1.556 whereas that against EBITDA is 7.256.
Stock Price History:
The Beta on a monthly basis for THC is 1.45, which has changed by 0.5764319 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $222.82, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is -1.34%, while the 200-Day Moving Average is calculated to be 12.63%.
Shares Statistics:
It appears that THC traded 972.73K shares on average per day over the past three months and 762970 shares per day over the past ten days. A total of 87.87M shares are outstanding, with a floating share count of 87.23M. Insiders hold about 0.75% of the company’s shares, while institutions hold 96.81% stake in the company. Shares short for THC as of 1767139200 were 2631452 with a Short Ratio of 2.71, compared to 1764288000 on 2908497. Therefore, it implies a Short% of Shares Outstanding of 2631452 and a Short% of Float of 4.03.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
. The current rating of Tenet Healthcare Corp (THC) is the result of assessments by 19.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $4.41, with high estimates of $4.75 and low estimates of $3.82.
Analysts are recommending an EPS of between $16.33 and $15.77 for the fiscal current year, implying an average EPS of $16.11. EPS for the following year is $16.36, with 20.0 analysts recommending between $17.8 and $14.2.
Revenue Estimates
In. The current quarter, 17 analysts expect revenue to total $5.47B. It ranges from a high estimate of $5.52B to a low estimate of $5.4B. As of. The current estimate, Tenet Healthcare Corp’s year-ago sales were $5.07BFor the next quarter, 17 analysts are estimating revenue of $5.44B. There is a high estimate of $5.51B for the next quarter, whereas the lowest estimate is $5.38B.
A total of 19 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.5B, while the lowest revenue estimate was $21.18B, resulting in an average revenue estimate of $21.27B. In the same quarter a year ago, actual revenue was $20.66BBased on 19 analysts’ estimates, the company’s revenue will be $22.18B in the next fiscal year. The high estimate is $22.55B and the low estimate is $21.8B.
